Owner Merck Patent GmbH

Inventors Gleitz, Johannes; Dorsch, Dieter; Mederski, Werner; Tsaklakidis, Christos; Cezanne, Bertram

Agent Davies Collison Cave

Pub. Number AU-B-2004226278

PCT Pub. Number WO2004/087646

Priority 60/483,897 02.07.03 US; 103 29 295.0 30.06.03 DE; 103 15 377.2 03.04.03 DE

Filing date 8 March 2004

Wipo publication date 14 October 2004

Acceptance publication date 29 July 2010

C07D 265/32 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/5377 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07C 275/26 (2006.01) Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group